Covetrus Announces Financial Results for Third Quarter of 2019

NEXT STORY
Forty Seven, Inc. Reports Third Quarter 2019 Financial Results and Recent Business Highlights
PREV STORY
BriaCell to Present Clinical Findings at the 2019 San Antonio Breast Cancer Symposium® December 12th and 13th
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Intra-Cellular Therapies Presents Data on Lumateperone, ITI-214 and ITI-333 at the 56th Annual Meeting of the American College of Neuropsychopharmacology

NEW YORK, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical ...

author_avatar
NASDAQ Market News

New Data at Cure SMA 2021 Highlight the Long-Term Efficacy of SPINRAZA® (nusinersen) and Biogen’s Commitment to Innovation in SMA Therapy

author_avatar
NASDAQ Market News

LIDDS completes a direct share issue raising SEK 9.0 million

author_avatar
NASDAQ Market News